Edition:
India

People: aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Capital Market

0.49USD
2:29am IST
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$0.49
Open
$0.49
Day's High
$0.51
Day's Low
$0.49
Volume
16,944
Avg. Vol
56,963
52-wk High
$3.15
52-wk Low
$0.38

Schimmel, Paul 

Dr. Paul R. Schimmel, Ph.D., is Independent Director of the Company. Dr. Schimmel is currently a director of Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, as well as a director of several private companies. Dr. Schimmel is an Ernest and Jean Hahn Professor at The Skaggs Institute for Chemical Biology at The Scripps Research Institute. He was formerly the John D. and Catherine T. MacArthur Professor of Biochemistry and Biophysics in the Department of Biology at the Massachusetts Institute of Technology. Dr. Schimmel holds a B.A. in biochemistry and biophysics from Ohio Wesleyan University and a Ph.D. from the Massachusetts Institute of Technology.

Basic Compensation

Total Annual Compensation, USD 40,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 122,878
Fiscal Year Total, USD 162,878

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --